Patents Assigned to HylaPharm, LLC
  • Platinum(IV) conjugates and methods of use
    Patent number: 11458163
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: October 4, 2022
    Assignees: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF
    Publication number: 20220177472
    Abstract: The present technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using the same for the treatment of cancers and as vaccine adjuvants.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 9, 2022
    Applicants: UNIVERSITY OF KANSAS, HYLAPHARM, LLC.
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • PLATINUM(IV) CONJUGATES AND METHODS OF USE
    Publication number: 20200330507
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Applicants: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai